Mar 12, 2018

Closer tailoring might boost wearable cardioverter defibrillators' benefit, alirocumab cuts deaths in post-acute coronary syndrome patients, the ODYSSEY Outcomes trial redefines secondary cardiovascular prevention, and how walking cuts postmenopausal women's heart failure risk.